Hôpitaux Civils de Colmar
Colmar, 68024, France
NCT Number: NCT06847087
Osteoporosis is a disease that causes many fractures. However, treatments exist such as anti-osteoporotic treatments, vitamin D supplementation and an adaptation of calcium intake. 80% of patients with an indication for anti-osteoporotic treatment are never treated with these anti-osteoporotic treatments after a first fracture. On the other hand, more than 84% of them are supplemented with calcium and vitamin D. It often appears in the practice of rheumatologists that some patients are supplemented while their dietary intake is sufficient, and vice versa. The objective of the study is therefore to take stock of the (in)adequacy between the dietary intake of patients and the supplementation prescribed to them following an osteoporotic-like fracture.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Colmar, 68024, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of the inadequacy between dietary and medicinal calcium intake by the Fardellone self-questionnaire and the patient's clinical record
Time frame: Day 1
percentage of patients
Time frame: Day 1
Results of densitormetry by a T score
Time frame: Day 1
Number of bone fractures the patient has already had before inclusion
Time frame: Day 1
Date of the first indication for the initiation of an anti-osteoporotic treatment.
This date is appearing in the medical record
Time frame: Day 1
Duration without treatment before a fracture occurs and type of the treatment
Time frame: Day 1
Implementation of educational measures by the rheumatologist in the event of inadequacy and optimization of anti-osteoporotic treatments
Centre Hospitalier de Colmar
Other
Study of the Adequacy Between Calcium Supplementation and Dietary Intake in Treatment-naive Patients After Fracture With a Fracture Suspected of Being Due to Bone Insufficiency, Consulting a Rheumatologist for the First Time in at Least 5 Years.
Acronym: MONTE-CRIST'OS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00067834
Bone Disease, Metabolic, Bone Diseases
Syracuse, New York, United States
View Trial DetailsNCT02060747
Bone Diseases, Bone Diseases, Metabolic
Paris, France
View Trial DetailsNCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial Details